NCT02202603View on ClinicalTrials.gov

A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions

Drug Safety

Interventions

DRUG

Teriparatide

single oral tablet

DRUG

Teriparatide

subcutaneous standard injection

DRUG

placebo

Oral placebo

Trial Locations (1)

91120,

HMO Clinical Research Center Hadassah Ein Kerem Medical Center, Jerusalem

Sponsors

Lead Sponsor

Entera Bio Ltd.

All Listed Sponsors

lead

Entera Bio Ltd.

INDUSTRY